Oral spironolactone may hold edge in female acne - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Oral spironolactone may hold edge in female acne

Topical treatment showed lesion reductions with minimal systemic exposure, but small, heterogeneous studies leave its clinical role uncertain.

  • By

  • Andrea Surnit

  • October 21, 2026

  • 4 min

Share

Original Source(s)

Oral spironolactone may hold edge in female acne

  • by Andrea Surnit

  • October 21, 2026

Related Content

AI may stumble on acne diagnosis

Dermatologists rated answers on diagnosis and treatment less favorably than responses addressing skin care and lifestyle.

The Role of Prebiotics, Probiotics, and Postbiotics in Managing Acne Vulgaris: A Comprehensive Review

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.